KaioM etc. continue to rank in, continuing clues regarding the license agreement with Asahi Kasei Pharma.
Kaiomu <4583> has ranked in (as of 14:32). Significant continued rise. After the market closed on the 20th, the company announced the conclusion of an exclusive licensing agreement with Asahi Kasei Pharma for its therapeutic antibody "Humanized Anti-CX3CR1 Antibody (PFKR)" and hit the stop-high yesterday. The buying star continues today. In addition to receiving 0.2 billion yen as a contract signing fee, Kaiomu will receive up to about 24.8 billion yen in milestone payments depending on the progress of future development and sales. Furthermore, after the product launch, it's expected to.
Toyo Suisan, Chuo Pharmaceutical etc (additional) Rating
Upgrade - Bullish Code Stock Name Securities Company Previous After Change ------------------------------------------------------- <1802> Obayashi Corporation SMBC Nikko Securities "2" "1" <1808> Haseko Corporation SMBC Nikko Securities "2" "1" Downgrade - Bearish Code Stock Name Securities Company Previous After Change ------------------------------------------------------- <3382>
November 22 [Today's Investment Strategy]
[FISCO Selected Stock] [Material Stock] Meisei Industries <1976> 1300 yen (11/21) The company's main business is thermal insulation work for power plants, chemical plants, LNG-related facilities, etc. They announced a share buyback of up to 1.4 million shares, equivalent to 2.86% of the issued shares, with a limit of 1.82 billion yen in value. On November 22, they will entrust the purchase in the Tokyo Stock Exchange's off-auction own-share purchase (ToSTNeT-3) market. The repurchased own shares will all be canceled on November 29. [Emerging Markets Stock] etc.
Pay attention to Chiyoda and Kobe Bussan [Today's individual stock trends]
In the US stock market on the 21st, the dow jones industrial average rose by 461.88 dollars to 43,870.35, the nasdaq composite index increased by 6.28 points to 18,972.42, and the chicago nikkei 225 futures were up by 190 yen compared to daytime in Osaka, reaching 38,230 yen. The exchange rate was 1 dollar = 154.50-60 yen. In today's Tokyo market, Chiyoda <8185> revised its profit financial estimates for the fiscal year ending February 2025 upward, Kobe Bussan <3038> reported that its October ordinary profits were 7.3 times higher than the same month last year, and the profit from the sale of investment securities was 0.221 billion yen.
Dai Nippon Printing, Honda, etc. [List of stock information from newspapers]
Dai Nippon Printing <7912> aims to mass produce glass substrates by 2027-2028, expanding towards larger sizes for AI applications. Amada <6113> establishes STEM education hub in Isehara, Kanagawa (The Nikkan Kogyo Shimbun, Page 3). Nissan <7201> - 6% of US employees apply for early retirement (The Nikkan Kogyo Shimbun, Page 3). Daito Trust Construction <1878> to train construction managers in Indonesia, plans to open specialized courses in local universities (The Nikkan Kogyo Shimbun, Page 4). Hitachi <6501> - Hitachi Energy acquires series compensation system from Swedish state-owned company.
TSE Growth Market 250 index futures outlook: a stable development is anticipated.
Today, the Tokyo Stock Exchange Growth Market 250 Index Futures are expected to show a firm performance. On the previous day, July 21, the Dow Jones Industrial Average in the US market closed at 43,870.35, up 461.88 points, and the Nasdaq closed at 18,972.42, up 6.28 points.The easing of geopolitical risks led to an opening rise. After opening, Chicago Fed President Goolsbee indicated that next year's interest rates are likely to be "lower than the current levels," leading to a sense of safety in interest rates and pushing the market higher. The Nasdaq faced an increase in long-term interest rates.